NEW YORK (GenomeWeb) – Researchers at the University of Washington have applied parallel-reaction monitoring (PRM) mass spec to the development of targeted phosphoproteomics assays.

The method, which was detailed in a paper published this week in Nature Methods, leverages PRM's reproducibility and simplicity to generate what the authors, led by UW researcher Judit Villén, described as rapid "plug and play" targeted phosphoprotein assays.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Sponsored by

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.